Special Issue “Bacterial Toxins and Cancer”

Infection is a major contributor to the development of cancer, with more than 15% of new cancer diagnoses estimated to be caused by infection [...].

• Publication year

  2024

• Venue

  International Journal of Molecular Sciences

• Publication date

  2024-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/ijms25042128PMID 38396805PMCID 10889233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cutaneous microbiome in skin cancer – A systematic review

  2024cited by this paper
• Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model

  2023cited by this paper
• Periodontitis and risk of cancer: Mechanistic evidence

  2023cited by this paper
• The microbiome and gynecologic cancer: cellular mechanisms and clinical applications

  2023cited by this paper
• Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects

  2023cited by this paper
• AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy

  2023cited by this paper
• Bacteria in cancer initiation, promotion and progression

  2023cited by this paper
• Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?

  2023cited by this paper
• Senescence and cancer — role and therapeutic opportunities

  2022cited by this paper
• The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment.

  2022cited by this paper
• Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity

  2022cited by this paper
• The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis

  2022cited by this paper
• Macrophage-Mediated Melanoma Reduction after HP-NAP Treatment in a Zebrafish Xenograft Model

  2022cited by this paper
• The role played by bacterial infections in the onset and metastasis of cancer

  2021cited by this paper
• Recent advances in microbial toxin-related strategies to combat cancer.

  2021cited by this paper
• From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin

  2021cited by this paper
• Effects of infections on the pathogenesis of cancer

  2021cited by this paper
• The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy

  2020cited by this paper
• Diphtheria Toxin

  2020cited by this paper
• Cancer and the Microbiome: Influence of the commensal microbiota on cancer, immune responses, and immunotherapy.

  2020cited by this paper
• Management of Clostridioides difficile infection in patients with inflammatory bowel disease

  2020cited by this paper
• Mutational signature in colorectal cancer caused by genotoxic pks+E. coli

  2020cited by this paper
• Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions

  2020cited by this paper
• Current state of melanoma diagnosis and treatment

  2019cited by this paper
• The role of bacterial toxins and spores in cancer therapy.

  2019cited by this paper
• An update on treatment options for pancreatic adenocarcinoma

  2019cited by this paper
• Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells

  2019cited by this paper
• Bacterial infections and cancer

  2018cited by this paper
• Melanoma treatment in review

  2018cited by this paper
• Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis.

  2018cited by this paper
• The role of toxins in Clostridium difficile infection.

  2017cited by this paper
• Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia

  2017cited by this paper
• Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages

  2017cited by this paper
• Infections and cancer: the “fifty shades of immunity” hypothesis

  2017cited by this paper
• Global burden of cancers attributable to infections in 2012: a synthetic analysis.

  2016cited by this paper
• Enteric glial cells are susceptible to Clostridium difficile toxin B

  2016cited by this paper
• Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer1

  2016cited by this paper
• Pancreatic cancer: yesterday, today and tomorrow.

  2016cited by this paper
• Shiga Toxin (Stx) Classification, Structure, and Function

  2014cited by this paper
• The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment

  2014cited by this paper
• An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine Tumors

  2013cited by this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cited by this paper
• HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response

  2011cited by this paper
• Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges

  2011cited by this paper
• Shiga toxins — from cell biology to biomedical applications

  2010cited by this paper
• The senescence-associated secretory phenotype: the dark side of tumor suppression.

  2010cited by this paper
• Toxins from bacteria.

  2010cited by this paper
• Vibrio cholerae: cholera toxin.

  2007cited by this paper
• The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.

  2007cited by this paper
• The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

  2006cited by this paper
• Structure and function of anthrax toxin.

  2002cited by this paper

• Cytotoxic effects of epsilon toxin from Clostridium perfringens on colon cancer cell lines (HT-29) and (Caco2) in terms of oxidative stress and inflammatory cytokines.

  2025cites this paper
• Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives.

  2024cites this paper